Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1111/JNS.12577 | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background and Aims: Diabetic sensorimotor polyneuropathy (DSP) is a common complication of diabetes. The Toronto Clinical Neuropathy Score (TCNS) is a useful tool for detecting DSP. However, it is not available in Spanish. The study aimed to translate and culturally adapt the TCNS and modified (mTCNS) scales into Spanish and evaluate their measurement properties. Methods: A multistep forward-backward method was used for translation and cultural adaptation. A panel of physicians subjected the final Spanish versions of TCNS and mTCNS (TCÑS, mTCÑS) to cognitive debriefing. Consecutive patients with diabetes mellitus and DSP were recruited from an outpatient clinic, and the TCÑS and mTCÑS were tested for construct validity, along with other measures. Results: The internal consistency of both TCÑS and mTCÑS was excellent, as evidenced by Cronbach's Alpha coefficients of 0.83 and 0.85, respectively. Furthermore, there was a robust positive correlation between TCÑS and mTCÑS. In addition, TCÑS was found to exhibit a strong negative correlation with sural sensory nerve action potential amplitude (r = −0.9206) and peroneal compound motor action potential amplitude (r = −0.729), while demonstrating a positive and strong correlation with the Michigan Neuropathy Screening Instrument (r = 0.713). Interpretation: The TCÑS and mTCÑS are reliable and valid translations of the original TCNS. The TCÑS and mTCÑS can be used to diagnose and measure the severity of neuropathy in Spanish-speaking patients with diabetes.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | IDIAQUEZ-RIOS, JUAN FRANCISCO | Hombre |
Universidad del Desarrollo - Chile
University Health Network University of Toronto - Canadá Univ Hlth Network - Canadá University Health Network - Canadá |
| 2 | Acosta, Ignacio | Hombre |
Universidad del Desarrollo - Chile
|
| 3 | Prat, Alberto | Hombre |
Universidad del Desarrollo - Chile
|
| 4 | Gattini, Francesca | Mujer |
Universidad del Desarrollo - Chile
|
| 5 | Pino, Francisca | Mujer |
Universidad del Desarrollo - Chile
|
| 6 | Barnett, Carolina | Mujer |
University Health Network University of Toronto - Canadá
Institute of Health Policy, Management and Evaluation - Canadá Univ Hlth Network - Canadá UNIV TORONTO - Canadá University Health Network - Canadá |
| Agradecimiento |
|---|
| Dr. Idiáquez Rios, Dr. Acosta, Dr. Prat, Dr. Gattini, Dr. Pinono do not report conflicts of interest. Dr. Barnett‐Tapia has served as member of advisory board for Alexion, argenx, Sanofi, and has been a consultant for Janssen and Takeda. She has research received grants from Grifols, Octapharma, US Department of Defence, MGNet and Muscular Dystrophy Canada. None of these are related to this work. |